BEIJING CENTERGATE TECHNOLOGIES (HOLDING) CO., LTD. Beijing Centergate Technologies (holding) Co., Ltd. Stock
Equities
000931
CNE000001030
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.33 CNY | -0.23% |
|
+10.46% | -26.24% |
| Sales 2022 | 2.06B 285M 391M | Sales 2023 | 2.28B 314M 433M | Capitalization | 4.42B 611M 840M |
|---|---|---|---|---|---|
| Net income 2022 | -42M -5.8M -7.98M | Net income 2023 | 48M 6.63M 9.12M | EV / Sales 2022 | 2.67 x |
| Net Debt 2022 | 864M 119M 164M | Net Debt 2023 | 749M 103M 142M | EV / Sales 2023 | 2.27 x |
| P/E ratio 2022 |
-108
x | P/E ratio 2023 |
90.6
x | Employees | 2,434 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 65.82% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.23% | ||
| 1 week | +10.46% | ||
| Current month | -5.46% | ||
| 1 month | -5.46% | ||
| 3 months | -17.52% | ||
| 6 months | -25.73% | ||
| Current year | -26.24% |
1 week
4.01
4.36
1 month
3.704.74
Current year
3.276.03
1 year
3.276.52
3 years
3.279.39
5 years
3.2712.36
10 years
3.2720.01
| Managers | Title | Age | Since |
|---|---|---|---|
Xue Wu Song
DFI | Director of Finance/CFO | - | 14-08-25 |
Zhan Jun Hou
PSD | President | 53 | 07-10-22 |
Hao Ran Xiang
IRC | Investor Relations Contact | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Xiao Chun Zou
BRD | Director/Board Member | 53 | 08-12-17 |
Zhan Jun Hou
PSD | President | 53 | 07-10-22 |
Xiu Hong Huang
BRD | Director/Board Member | 51 | 09-12-13 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +1.51% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-30 | 4.33 | -0.23% | 12,083,740 |
| 24-04-29 | 4.34 | +5.08% | 14,429,580 |
| 24-04-26 | 4.13 | -0.24% | 11,943,640 |
| 24-04-25 | 4.14 | +2.22% | 13,394,640 |
| 24-04-24 | 4.05 | +1.00% | 7,689,664 |
End-of-day quote Shenzhen S.E., April 29, 2024
More quotes
Beijing Centergate Technologies Holding Co Ltd is a China-based company principally engaged in biomedicine, personal care products, elderly care services and other businesses. The Company operates its businesses through four segments. The Biopharmaceutical segment is mainly engaged in the production and sales of external reagents, tablets, injections and other products. The Commercial Concrete segment is mainly engaged in the production and sales of concrete. The Elderly Care and Health segment mainly provides elderly care services. The Other segments mainly provide property management services, sales of existing properties, hotel business and others. The Company mainly operates its businesses in the domestic market, with North China and Northeast China as its main markets.
Sector
Pharmaceuticals
Calendar
2024-05-10
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| -26.24% | 451M | |
| +34.00% | 704B | |
| +29.29% | 577B | |
| -7.75% | 348B | |
| +18.53% | 327B | |
| +4.95% | 288B | |
| +13.79% | 234B | |
| +4.93% | 198B | |
| -9.78% | 194B | |
| -4.89% | 147B |
- Stock Market
- Equities
- 000931 Stock
